Ironwood Pharma's total assets for Q2 2026 were $285.13M, a decrease of -34.39% from the previous quarter. DE:I76 total liabilities were $446.97M for the fiscal quarter, a -31.42% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.